Connect with us

News

Paytm launched a new facility, now you can easily book slots for Vaccine

Published

on

Paytm

Apart from finding available slots for Vaccines on Paytm, now you can also book slots to get Vaccines installed. The company said about this on Monday. Paytm said, “Paytm users can now also search and book slots for vaccines at their nearest centers through the Paytm app. With this service, Indians can easily book slots to get vaccinated and immunity. This will help in fighting against the current pandemic.

Many companies are seeking approval

Covin chief RS Sharma recently said that more than a dozen companies, including major digital companies like Paytm, MakeMyTrip and Infosys, are seeking approval to provide booking service for the vaccine. The government had last month issued new guidelines to integrate Covin with third-party apps, paving the way for digital apps to provide such a facility.

Already given this service

Earlier in May, Paytm launched the ‘Vaccine Founder’ facility on its app to help users find slots for vaccines. A Paytm spokesperson said, “It is our endeavor to help India come out stronger from this pandemic. Our Vaccine Finder will help citizens to easily book slots and get vaccinated at the nearest centers “

Apart from finding available slots for Vaccines on Paytm, now you can also book slots to get Vaccines installed. The company said about this on Monday. Paytm said, “Paytm users can now also search and book slots for vaccines at their nearest centers through the Paytm app.

India on Tuesday reported 60,471 new Covid-19 cases

India on Tuesday reported 60,471 new Covid-19 cases, the lowest in 75 days, and 2,726 deaths in the last 24 hours, according to data from the Union Health Ministry. The total number of coronavirus cases in the country now stands at 2,95,70,881 while the death toll has reached 3,77,031. There are 9,13,378 active cases at present while 2,82,80,472 people have recovered so far. As many as 25,90,44,072 people have been vaccinated, the health ministry said.

Bharat Biotech said that the supply price of its Covid-19 vaccine Covaxin to the central government at Rs 150 per dose is not sustainable in the long run. “Hence a higher price in private markets is required to offset part of the costs,” it said in a statement.

Also Read :

Hackers’ claim of Cowin data leak baseless: Centre on Cowin data leak

PUBG: New State Gameplay Footage Shows Map, Vehicles, and More in Closed Alpha That Went Live Over the Weekend

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright © 2020 - 2021 TechZimo.com, All rights reserved.